Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE
Authors:
Top Cited Papers
- 28 August 2024
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 25 (11) , e602-e610
Abstract
No abstract availableKeywords
Funding Information
- Gustave Roussy
- Université Paris-Saclay
This publication has 8 references indexed in Scilit:
- ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*International Journal of Gynecological Cancer, 2023
- Cancer of the ovary, fallopian tube, and peritoneum: 2021 updateInternational Journal of Gynecology & Obstetrics, 2021
- ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancerInternational Journal of Gynecological Cancer, 2021
- Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization GroupThe Lancet Oncology, 2021
- Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†Annals of Oncology, 2020
- Revised FIGO staging for carcinoma of the cervix uteriInternational Journal of Gynecology & Obstetrics, 2019
- Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2001
- Purpose of Quality Standards for Infectious DiseasesClinical Infectious Diseases, 1994